RESET BIOSCIENCE LLC – Trademark Portfolio
Entity Type: 16
RESET BIOSCIENCE LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CREATING REVOLUTIONARY BREAKTHROUGHS IN BIOAVAILABILITY. The owner is based in AUSTIN, TX.
8201 E. RIVERSIDE DRIVE, SUITE 650
AUSTIN, TX 78744
Showing of trademarks Trademarks
Trademark Classifications
RESET BIOSCIENCE LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does RESET BIOSCIENCE LLC have?
RESET BIOSCIENCE LLC has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned.
What trademark classes does RESET BIOSCIENCE LLC file in?
RESET BIOSCIENCE LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are RESET BIOSCIENCE LLC's most well-known trademarks?
RESET BIOSCIENCE LLC's registered trademark portfolio includes well-known marks such as CREATING REVOLUTIONARY BREAKTHROUGHS IN BIOAVAILABILITY. These are among 1 currently registered trademark in the portfolio.
What is RESET BIOSCIENCE LLC's trademark registration success rate?
RESET BIOSCIENCE LLC has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.